Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood

Journal of Epidemiology and Community Health

Volumn 62, Issue 6, 2008, Pages 484-491

  Pollitt, R A ^a,c   Kaufman, J S ^a   Rose, K M ^a   Diez Roux, A V ^b   Zeng, D ^a   Heiss, G ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT; AFRICAN AMERICAN; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; EDUCATION; HEALTH RISK; IMMUNE RESPONSE; REGRESSION ANALYSIS; RISK FACTOR; SOCIOECONOMIC CONDITIONS; SOCIOECONOMIC STATUS;

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; EDUCATIONAL STATUS; EUROPEAN AMERICAN; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE; LIFESPAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RESIDENTIAL AREA; RETROSPECTIVE STUDY; SOCIAL CLASS; SOCIOECONOMICS; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN AMERICANS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHRONIC DISEASE; EDUCATIONAL STATUS; EMPLOYMENT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FIBRINOGEN; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LINEAR MODELS; NORTH CAROLINA; QUALITY OF LIFE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SOCIAL CLASS; VON WILLEBRAND FACTOR;

EID: 44349184469     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.2006.054106     Document Type: Article

References (62)

1. Kunst AE, Groenhof F, Andersen O, et al. Occupational class and ischemic heart disease mortality in the United States and 11 European countries. Am J Public Health 1999;89:47-53.
2. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88:1973-98.
3. Strike PC, Steptoe A. Psychosocial factors in the development of coronary artery disease. Progr Cardiovasc Dis 2004;46:337-47.
4. Armstrong D, Barnett E, Casper M, et al. Community occupational structure, medical and economic resources, and coronary mortality among US blacks and whites, 1980-1988. Ann Epidemiol 1998;8:184- 91.
5. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med 2001;345:99-106.
6. Diez-Roux AV, Nieto FJ, Tyroler HA, et al. Social inegualities and atherosclerosis. The atherosclerosis risk in communities study. Am J Epidemiol 1995;141:960-72.
7. Lynch JW, Kaplan GA, Salonen JT. Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse. Soc Sci Med 1997;44:809-19.
8. Galobardes B, Lynch JW, Davey Smith G. Childhood socioeconomic circumstances and cause-specific mortality in adulthood: systematic review and interpretation. Epidemiol Rev 2004;26:7-21.
9. Pollitt RA, Rose KM, Kaufman JS. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC Public Health 2005;5:7.
10. Hertzman C, Power C, Matthews S, et al. Using an interactive framework of society and lifecourse to explain self-rated health in early adulthood. Soc Sci Med 2001;53:1575-85.
11. Power C, Hertzman C. Social and biological pathways linking early life and adult disease. Br Med Bull 1997;53:210-21.
12. Kuh D, Power C, Blane D, et al. Social pathways between childhood and adult health. In: Kuh D, Ben-Shlomo Y, eds. A life course approach to chronic disease epidemiology. Oxford: Oxford University Press, 1997:169-98.
13. Smith GD, Gunnell D, Ben-Shlomo Y. Lifecourse approaches to socio-economic differentials in cause-specific adult mortality. In: Leon DA, Walt G, eds. Poverty, inequality and health: an international perspective. Oxford: Oxford University Press, 2001:88-124.
14. Heslop P, Smith GD, Macleod J, et al. The socioeconomic position of employed women, risk factors and mortality. Soc Sci Med 2001;53:477-85.
15. Smith GD, Hart C, Blane D, et al. Lifetime socioeconomic position and mortality: prospective observational study. BMJ 1997;314:547-52.
16. Lawlor DA, Ebrahim S, Davey Smith G. Socioeconomic position in childhood and adulthood and insulin resistance: cross sectional survey using data from British women's heart and health study. BMJ 2002;325:805.
17. Claussen B, Davey Smith G, Thelle D. Impact of childhood and adulthood socioeconomic position on cause specific mortality: the Oslo Mortality Study. J Epidemiol Community Health 2003;57:40-5.
18. Pensola TH, Martikainen P. Cumulative social class and mortality from various causes of adult men. J Epidemiol Community Health 2003;57:745-51.
19. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
20. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
21. Huber SA, Sakkinen P, Conze D, et al. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 1999;19:2364-7.
22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
23. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
24. Kumari M, Marmot M, Brunner E. Social determinants of von Willebrand factor: the Whitehall II study. Arterioscler Thromb Vasc Biol 2000;20:1842-7.
25. Owen N, Poulton T, Hay FC, et al. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun 2003;17:286-95.
26. Panagiotakos DB, Pitsavos C, Manios Y, et al. Socio-economic status in relation to risk factors associated with cardiovascular disease, in healthy individuals from the ATTICA study. Eur J Cardiovasc Prev Rehabil 2005;12:68-74.
27. De Ferranti S, Rifai N. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 2002;317:1-15.
28. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477- 82.
29. Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:1102-8.
30. Jager A, van Hinsbergh VW, Kostense PJ, et al. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 1999;19:3071-8.
31. Tunstall-Pedoe H, Woodward M, Tavendale R, et al. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ 1997;315:722-9.
32. Koenig W, Sund M, Frohlich M, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
33. Ridker PM, Haughie P. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease. J Invest Med 1998;46:391-5.
34. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
35. Zieske AW, Malcom GT, Strong JP. Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med 2002;21:213-37.
36. Brunner E, Davey Smith G, Marmot M, et al. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 1996;347:1008-13.
37. Wilson TW, Kaplan GA, Kauhanen J, et al. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study. Am J Epidemiol 1993;137:292-300.
38. Kivimaki M, Lawlor DA, Juonala M, et al. Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2005;25:2197-202.
39. Pollitt RA, Kaufman JS, Rose KM, et al. Early-life and adult socioeconomic status and inflammatory risk markers in adulthood. Eur J Epidemiol 2007;22:55-66.
40. ARIC. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
41. Life Course Socioeconomic Status, Social Context and Cardiovascular Disease (LC-SES) Study. Manual of Procedures 2005.
42. Wright EO. The class analysis of poverty. Int J Health Serv 1995;25:85-100.
43. Wright EO. Class counts: comparative studies in class analysis. Cambridge: Cambridge University Press; Paris Maison des Sciences de l'Homme, 1997.
44. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health 1997;18:341-78.
45. Rose KM, Wood JL, Knowles S, et al. Historical measures of social context in life course studies: retrospective linkage of addresses to decennial censuses. Int J Health Geogr 2004;3:27.
46. Diez-Roux AV, Nieto FJ, Muntaner C, et al. Neighborhood environments and coronary heart disease: a multilevel analysis. Am J Epidemiol 1997;146:48-63.
47. Smith GD, Hart C. Life-course socioeconomic and behavioral influences on cardiovascular disease mortality: the collaborative study. Am J Public Health 2002;92:1295-8.
48. Papp AC, Hatzakis H, Bracey A, et al. ARIC Hemostasis Study - I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 1989;61:15-9.
49. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-46.
50. Chambless LE, McMahon R, Wu K, et al. Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study. Ann Epidemiol 1992;2:723-33.
51. Beck JD, Elter JR, Heiss G, et al. Relationship of periodontal disease to carotid artery intima-media wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001;21:1816-22.
52. Slade GD, Ghezzi EM, Heiss G, et al. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 2003;163:1172-9.
53. Horton NJ, Lipsitz SR. Multiple imputation in practice: Comparison of software packages for regression models with missing variables. Am Stat 2001;55:244-54.
54. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods 2002;7:147-77.
55. Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods 2001;6:330-51.
56. Royston P. Multiple imputation of missing values. Stata J 2004;4:227-41.
57. Duncan BB, Schmidt MI, Pankow JS, et al. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study. Diabetes 2003;52:1799-805.
58. Kleinbaum DG, Kupper LK, Muller KE, et al. Applied regression analysis and other multivariable methods, 3rd ed. Washington: Rrooks/Cole Publishing Company, 1998.
59. Borrell LN, Diez Roux AV, Rose K, et al. Neighbourhood characteristics and mortality in the Atherosclerosis Risk in Communities Study. Int J Epidemiol 2004;33:398-407.
60. Godfrey KM, Barker DJ. Fetal programming and adult health. Public Health Nutr 2001;4:611-24.
61. Zhu J, Nieto FJ, Horne BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001;103:45-51.
62. Berney LR, Blane DB. Collecting retrospective data: accuracy of recall after 50 years judged against historical records. Soc Sci Med 1997;45:1519-25.